Astrana Health, Inc. insider trading
Every open-market purchase and sale by Astrana Health, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Does following Astrana Health, Inc.’s insiders pay?
From August 6, 2013 to June 17, 2022, 14 insiders reported 59 open-market purchases and 33 sales not made under a pre-set plan in Astrana Health, Inc. Twelve months after each purchase was reported, the shares were +59.0% against the S&P 500 on average (median −10.7%), over 49 purchases with a full year of prices; 31% beat the index. After sales, the shares moved +30.5% against the index over 12 months (a negative figure means selling was the right call). Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on June 14, 2019 into $22,518 by November 2, 2026, +11.7% a year. It held shares 54% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $18,818 (+9.0% a year), and held throughout $29,178 (+15.7%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Allied Physicians Of California, A Professional Medical Corp | 10% owner | 25 | −16.8% (25) | 12% | 1 | +64.5% (1) | June 17, 2022 |
| Hosseinion Warren | Co-Chief Executive Officer | 0 | — | — | 19 | 0.0% (19) | November 30, 2018 |
| Vazquez Adrian | Chief Medical Officer | 0 | — | — | 10 | +103.4% (10) | April 28, 2021 |
| Augusta Gary | Director | 9 | — | — | 0 | — | December 16, 2014 |
| Sim Kenneth T. | Executive Chairman and Co-CEO | 7 | +149.3% (7) | 57% | 0 | — | September 15, 2020 |
| Lam Thomas S. | President and Co-CEO | 6 | +172.9% (6) | 50% | 0 | — | September 15, 2020 |
| Sim Brandon | See Remarks | 4 | +280.9% (4) | 100% | 0 | — | May 17, 2021 |
| Eng Michael F. | Director | 3 | −18.2% (3) | 0% | 0 | — | December 6, 2019 |
| Chin Eric | Chief Financial Officer | 2 | +89.6% (2) | 50% | 0 | — | June 12, 2020 |
| Young Albert Waichow | Chief Administrative Officer | 1 | −9.6% (1) | 0% | 1 | −24.5% (1) | June 17, 2021 |
| Dong Linda | Director | 0 | — | — | 1 | −37.8% (1) | June 17, 2022 |
| Fawcett Mark | Director | 1 | −10.7% (1) | 0% | 0 | — | June 13, 2019 |
| Nihalani Suresh | Director | 1 | — | — | 0 | — | August 6, 2013 |
| Schmidt David | Director | 0 | — | — | 1 | −30.3% (1) | August 19, 2021 |
When several insiders traded Astrana Health, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Astrana Health, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged +17.9% against the index. After 1 selling crowd, +5.7%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| June 30, 2021 | 3 selling | +49.8% | +5.7% | −27.9% |
| September 30, 2020 | 3 buying | −12.2% | +35.4% | +377.6% |
| June 28, 2019 | 4 buying | +4.4% | +0.4% | −10.1% |